Bastone Bronwen's Form 4 filing
Enfusion, Inc. (ENFN) · filed Aug 10, 2023
- Accession no.
- 0001104659-23-089937
- Filed
- Aug 10, 2023
- Trade date
- Aug 8-9, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $457.6. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bastone BronwenCIK 0001927636 | Officer (Chief People Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 8, 2023 | Class A Common Stock | AGrant or awardAcquired | +153 | $0.00 | $0 | 156,657 | Direct | |
| Aug 9, 2023 | Class A Common Stock | SSaleDisposed | −55 | $8.32F3 | −$457.6 | 156,602 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.13 to $8.48. Full information regarding the number of shares sold at each separate price will be furnished to the SEC staff upon request.
Referenced by the price of 1 transaction in Table I.